Literature DB >> 1625737

Breast cancer (3).

J R Harris1, M E Lippman, U Veronesi, W Willett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1625737     DOI： 10.1056/NEJM199208133270706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

1.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

Authors:  D C Márquez; J Lee; T Lin; R J Pietras
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

2.  Dyadic coping in metastatic breast cancer.

Authors:  Hoda Badr; Cindy L Carmack; Deborah A Kashy; Massimo Cristofanilli; Tracey A Revenson
Journal:  Health Psychol       Date:  2010-03       Impact factor: 4.267

3.  Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.

Authors:  Diana C Márquez-Garbán; Manuel Gorrín-Rivas; Hsiao-Wang Chen; Colin Sterling; David Elashoff; Nalo Hamilton; Richard J Pietras
Journal:  Cancer Lett       Date:  2019-02-13       Impact factor: 8.679

4.  Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue.

Authors:  R Bonacci; A Pinchera; P Fierabracci; A Gigliotti; L Grasso; C Giani
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

5.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 6.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

7.  The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.

Authors:  Oguzhan Alagoz; Mehmet Ali Ergun; Mucahit Cevik; Brian L Sprague; Dennis G Fryback; Ronald E Gangnon; John M Hampton; Natasha K Stout; Amy Trentham-Dietz
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.

Authors:  R D Whelan; B T Hill
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.

Authors:  S P Lehrer; R K Schmutzler; J M Rabin; B S Schachter
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Predicting recurrence in axillary-node negative breast cancer patients.

Authors:  D Rosner; W W Lane
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.